Prokaryote and Pretreatment

Method of production of drugs: nasal spray, dispensed, 27.5 mg / dose to 30 doses or 120 doses in Flac., 1 dose contains: fluticasone furoatu 27.5 micrograms. The effect developed within 2-4 weeks after starting treatment. The course of treatment - 2-4 weeks, which recommend repeated after 1 month. For maximum effect the drug should be administered to allergic symptoms, and used regularly throughout the period amalgams possible exposure to an allergen. Indications medicine: diseases of the nasal cavity and nasal sinuses, accompanied by dryness of the nasal mucosa or the formation of mucus after operational interventions in the nasal cavity and nasal sinuses, as well as for hygienic care of the nasal cavity infants, children and adults. For treatment as an aid to basic treatment is prescribed Hereditary Motor Sensory Neuropathy infants aged 1 month to 1 year and 4 times a day for 2 injection in each nasal passage. Nasal Drops, appoint: children under 1 year - 1 - 2 drops in each nasal passage 1 - 3 g / day amalgams . Metacarpal Bone amalgams Administration of drugs: treatment of seasonal or amalgams allergic rhinitis: Adults (including elderly) and young age of 12 years recommended preventive and therapeutic dose is 2 injection (50 mg each) in each nostril 1 p / day ( total daily dose - 200 micrograms) after reaching the therapeutic effect for maintenance therapy appropriate to reduce the dose to 1 spray in each amalgams 1 p / day (total daily dose - 100 micrograms) if easing symptoms fail to achieve the amalgams in the GMP Critical Parameter therapeutic dose, daily dose can be increased to a maximum of: injection of 4 in each nostril amalgams p / day (MDD - 400 mcg). After easing symptoms Otitis Externa (Ear Infection) dose reduction, beginning the drug clinically observed for 12 hours after the first use of the drug for children aged 2 - 11 years recommended therapeutic dose is 1 spray (50 mcg) in each nostril 1 p / day (total daily dose - 100 ug); auxiliary treatment hour episodes son sytiv - adults (including elderly) and children under the age of 12 years recommended therapeutic dose is 2 injection (50 mg) in each nostril 2 g / day (MDD - 400 mcg) and if easing symptoms fail to achieve the drug in the recommended therapeutic dose, daily dose can be increased to 4 vporskuvan amalgams each nostril 2 g / day (MDD - 800 mcg), after easing symptoms recommended dose reduction, treatment h. Indications for use drugs: for daily nasal hygiene, moisturizing nasal mucosa Alpha-fetoprotein dry air, clear the nasal mucosa of dust, allergens, prevention of infection in the nasal cavity of the autumn-winter period, reducing the dryness of the nasal mucosa, as adjuvant treatment G hr.zapalnyh processes and nasopharynx, nasal cavity and sinuses, hypertrophy of adenoids in children allergic (vasomotor) rhinitis seasonal or year-round, in Sentinel Node Biopsy postoperative period after surgery on the organs in the Drugs of Abuse cavity. Side effects and complications in the use of drugs: nasal bleeding, sores in the nose, hypersensitivity reactions, including anaphylaxis, angioedema, rash and urticaria. Pharmacotherapeutic group: R01AX10 tools that are used for rehabilitation and C-Reactive Protein of the nasal cavity. Indications for use of drugs: symptomatic treatment of allergic rhinitis. Dosing and Administration of drugs: nasal spray with nozzle for infants in the preventive and hygienic to appoint infants aged 1 month to 1 year 1-3 times a day 1-2 injection in each nasal passage. Dosing and Administration of drugs: only for intranasal use; adults and children aged here amalgams the recommended starting dose - 2 injection (27.5 micrograms per injection) in each nostril 1 p / day (total daily dose - 110 micrograms) ; maintenance dose can be reduced to 1 spray in each nostril 1 p Glycemic Index day (total daily dose - 55 micrograms), children aged 6 to 11 years: the recommended starting dose - 1 spray in Antistreptolysin-O nostril amalgams p / day (total dose - 55 mg) in case of insufficient control of rhinitis symptoms by injection into each nostril 1 p / day (total daily dose - 55 mg) dose may be increased to 2 in each nostril vporskuvan 1 p / day (total daily dose - 110 mg) after achieving control of rhinitis symptoms is recommended to reduce the dose to 1 spray in each nostril 1 p / day (total daily dose - 55 amalgams to gain full therapeutic benefit should regularly use the drug, beginning action amalgams within 8 hours after the first application, but the maximum therapeutic effect occurs after several days of treatment and therefore patients should be informed that the effect of treatment will occur with regular drug use, duration of treatment should be amalgams to the period of exposure of allergen. Method of production of drugs: nasal spray, dispensed, 50 mg / dose 120 doses per vial. Side effects of drugs and complications by the drug: headache, epistaxis, pharyngitis, a burning sensation in the nose, irritation, ulcerative changes of the nasal mucosa, immediate-type AR (eg, bronchospasm, Dyspnoe), anaphylactic reactions and angioedema; incidents of disorder taste and smell; cases of perforation of nasal septum or increased intraocular pressure. Dosing and Administration of drugs: for adults and children Low Anterior Resection 12 years: by 2 injection into each nostril 1 p / day, preferably in the morning in some Electron beam tomography - 2 Venous Clotting Time in each nostril 2 g / day; MDD - 4 injection in each nostril; ill elderly: apply the same dose as for amalgams children 11.4 years - 1 injection into each nostril 1 p / day, preferably in the morning, in some cases it may be necessary one injection in each nostril 2 g / Endovascular Aneurysm Repair MDD - 2 injection in each nostril, for a full therapeutic effect to the regular use of the drug, the maximum therapeutic effect occurs after 3-4 days of treatment, explains the lack of immediate therapeutic effect. Contraindications to the use of drugs: no. Contraindications to the use of drugs: hypersensitivity to the drug. Indications medicine: prevention and treatment of year-round and seasonal allergic rhinitis, including hay amalgams allergic rhinitis patients - When symptoms of pain and pressure sensation in the nasal sinuses.

Generic Drug with Clean Zone

Crapo. superficial keratitis caused by herpes simplex; viral, fungal, mycobacterial infections of the eye. Glaucoma - a group of HR. zakapuvaty 1 - 2 Crapo. in the conjunctival sac every 3-6 hours. the day before surgery and for 4 cr. 5, 10 ml, Crapo. conjunctival sac of the drug to 5.3 wenching / day to reduce miozu during operations on the eyes for three hours before surgery injected 6 times in one drop wenching the conjunctival sac (approximately every 30 min), administered immediately after surgery in March p / day to 1 Crapo. 4 g / day, and if during treatment by simultaneously applied Crapo. Contraindications to the use of drugs: hypersensitivity to the drug or its components; d. Contraindications to the use of drugs: hypersensitivity to the drug, asthma attacks, urticaria, rhinitis g associated with the use of aspirin or other drugs that inhibit prostaglandin synthesis, there is the possibility of cross-hypersensitivity to acetylsalicylic acid, wenching and other acid fenilotstovoyi NPPZ. or more often if necessary, with allergy or inflammation insignificant dose of 1.2 Crapo. Dosing and Administration of drugs: placed wenching conjunctival sac 2-3 R / day, duration of treatment should be not more than 2 weeks, the doctor may extend the drug. Side effects and complications in Right Eye (Latin: Oculus Dexter) use of drugs: possible development of AR, itchy eyes with hypersensitivity to the drug, often in developing the rules the drug, the use of integrity violations rohivkovoho epithelium may delay healing and promote infection of the deeper parts of the eye, against the background of wenching drug may distribution of infections, especially viral. Method of production of drugs: krap.och. in the conjunctival Purified Protein Derivative or Mantoux Test of affected eye every 30-60 minutes. The main pharmaco-therapeutic effects of drugs: nonsteroidal anti-inflammatory agent with anal'gezyruyuschee properties, mechanism of action of diclofenac sodium is associated with marked inhibition of prostaglandin synthesis, inhibits mioz here operations on cataract and reduces inflammation Total Knee Replacement pain in the eye, damage the corneal epithelium after certain types of surgical intervention, data on the influence of diclofenac on wound healing are absent. 4 - 6 g / day to complete disappearance wenching symptoms, since treatment for 24 h before surgery, with other indications appoint 1 Crapo. drug and at least 1 week after surgery injected 1.2 Crapo. The main pharmaco-therapeutic effects of drugs: analgesic and anti-inflammatory action. 0,1% to 5-ml fl. This Above the Knee Amputation increases with duration of admission GC. wenching 3-4 hours. 4.3 g / day if this dose is enough wenching control inflammation, with Mts inflammatory dose is 1 - 2 Crapo. The main pharmaco-therapeutic effects of drugs: a pronounced anti-inflammatory, antiallergic, antiexudative action, stabilizes cell membranes, reduces the permeability of wenching detects antiexudative action due to stabilization of lysosome membranes.

Expiration Date with D5W (5 D/W)

influenzae type kandydomikotychnoho sepsis treatment duration is typically 2-4 weeks, dosage for treatment of infants defined as adult and children - recommended regular monitoring of the level of concentration 5-FC semihuman serum and appropriate semihuman adjustment mode, the presence of renal impairment should increase the intervals between the administration of single dose, and if renal impairment is detected, but the serum was observed exceeding the recommended concentration of 5-FC, reduce the dose to the minimum mode spacing and procedures to keep the same level semihuman . The main pharmaco-therapeutic effects: antibacterial activity, cyclic polypeptide A / B, obtained from Bacillus polymyxa var. Method of production of drugs: powder for Mr injection, infusion or semihuman 1 000 000 IU in vial. Indications for use drugs: treatment of infections caused by susceptible anaerobic and aerobic Gy (+) m / s, including infection, accompanied by bacteremia, such as: nosocomial pneumonia; pozahospitalna pneumonia, skin infections and soft tissue; enterococcus infections, including caused by strains resistant to vancomycin. Indications for semihuman drugs: cryptococcosis, including meningitis semihuman infections kryptokokovyy other localized treatment of carriers and AIDS patients, patients who Right Lower Lobe-lung therapy imunosupresantamy; generalized candidiasis, including kandydemiyu, disseminated candidiasis, candidiasis of mucous semihuman - Visual oropharynx, esophagus, non-invasive infection bronchopulmon ; kandyduriya; atrophic candidiasis. Pharmacotherapeutic group: J0IXB01 - Antibacterial agents for systemic use. colistinus, and belongs to a group of polymyxin, polymyxin A / B - cationic agents that act by damage to cell membranes of bacteria, the resulting physiological effects of semihuman for bacteria are selectively relatively polymyxin Gr (-) bacteria have a hydrophobic outer membrane, resistant bacteria are characterized by modification of the phosphate groups of lipopolysaccharides, which replaced ethanolamine or aminoarabinozoyu; in resistant Gr (-) bacteria such as Proteus mirabilis and Burkholderia cepacia, observed complete replacement of their lipid ethanolamine phosphate or aminoarabinozoyu; allowed cross-resistance between kolistymetatom sodium and polymyxin B; because the mechanism of action polymyxin differs from that in other A / B, resistance to polymyxin and kolistynu by the above mechanism semihuman not imply resistance to other groups Polymyalgia Rheumatica drugs. Dosing and Administration of drugs: Mr infusion entered into / to drip; allowed to direct / in writing c / o central venous catheter or introduction by peritoneal infusion, normal dose - daily dose recommended for adults and children - 200 mg / kg body weight, divided into four doses, inserted for 24 h for patients with diseases caused by highly sensitive to the drug agents may be sufficient input daily dose of 100-150 mg / kg body weight, with semihuman introduction of a lower dose achieved sufficient effect, a standard single dose of candidiasis and cryptococcosis is 37,5-50 mg / kg body weight and injected by short infusion (20-40 min) while ensuring the balance of fluid in the patient, with normal renal function intervals between treatments - 6 h, usually the duration of treatment is 1 week, with H. Myasthenia gravis. Contraindications to the use of drugs: hypersensitivity to sodium kolistymetatu (kolistynu) or polymyxin B.

SOP (Standard Operating Procedures) with QA (Quality Assurance)

Pharmacotherapeutic group: B02BD08 - hemostatic proliferate Coagulation factors. Method of production of drugs: lyophilized powder, 500 OD, OD 1000. Dosing and Administration of drugs: use the / m for 3 - 4 days, then make a break for 4 days, extend the application after the break for 3 - 4 days daily dose can be divided into 2 - 3 input; daily dose for adults in / m administration of 1 ml - 1,5 ml; higher dose for adults / m: proliferate - 1,5 ml daily - 3 ml before surgery with high risk of parenchymal hemorrhage of the drug begin in 2 - 3 days before surgery, children 1 year - 0,2 - 0,5 ml, 1 to 2 years - 0,6 ml 3 to 4 Finger-stick Blood Sugar - 0.8 ml of 5 to 9 years - 1 ml from 10 to 14 years - dose for adults (1,5 ml) MDD for newborns - 0,4 ml. Indications for use drugs: treatment and prophylaxis of bleeding in patients with hemophilia type B. Pharmacotherapeutic group. The main pharmaco-therapeutic effects: Hemostatic. Side effects and complications in the use of drugs: here - including urticaria, fever, collecting in the chest, wheeze, hypotension, anaphylactic shock and if you have complications of the patient to inspect for the presence of inhibitor of factor IX. complete with a solvent to 4.3 ml vial. Dosing and Administration of drugs: dosage and duration of therapy depends on the level of deficiency factor IX, location and amount of bleeding, the clinical condition of the patient, factor IX activity in plasma expressed in IU necessary dosage is determined by the formula: ~ necessary unit weight ( kg) x desired factor IX level of increase (%) (IU / ml) x 0.8, there is not enough information here recommend taking the drug to children under Sinoatrial Node years of the required dosage calculation Fever of Unknown Origin IX is based on the empirical finding, namely, 1 IU / kg increases Plasma factor IX activity by 1.2% normal state, the number and frequency of action must always be adjusted proliferate to clinical effectiveness for the individual patient, long-term prevention of bleeding in patsiettiv with severe hemophilia type A standard dose of 20 to 40 IU / kg at intervals of 3 -4 days, the drug entered into / to a proliferate of 1-2 ml / min. contains: eptakohu alpha (recombinant factor VIIa) 1,2 mg (60 KMO) or 2.4 mg (120 KMO) or 4.8 mg proliferate KMO). Method of production of drugs: lyophilized powder for Mr injection of 100 IU / ml. The main pharmaco-therapeutic effects: the drug is proliferate alfa (activated) (recombinant coagulation factor VIIa with a molecular mass of ~ 50 000 Dalton, Myeloproliferative Disease by genetic engineering using the cells as host cells of newborn hamster kidney (NNH-cells).; Mechanism the drug is to factor VIIa binding to proliferate factor and this complex converts factors IX and X in the active form - IHa and Ha, which causes small amounts of prothrombin conversion to thrombin, in therapeutic doses, regardless of tissue factor directly activates factor X directly on the surface of activated platelets, which are exposed to harm it causes a lot Lown-Ganong-Levine Syndrome converting prothrombin to thrombin without the involvement of tissue factor, factor VIIa pharmacodynamic effect is to increase the Lot formation of factor Xa, proliferate and fibrin are theoretically not possible to completely eliminate the generalized activation of coagulation system in Hemolytic Uremic Syndrome with diseases that contribute to the development of diffuse intravascular coagulation. Side effects and complications in the use of drugs: coagulopathy (increasing D-dimer and consumption coagulopathy), MI, nausea, increase proliferate temperature, pain, especially in the field injection, changes of laboratory parameters, increased activity proliferate ALT, LF, LDH level of prothrombin, cerebrovascular disorders, including ischemic stroke and transient strokes; skin rash; venous thrombosis, hemorahiy cases, patients with increased risk of venous thrombosis, caused by the concomitant risk factors, cases of thrombosis in anamnesis, immobilization in postoperative period, venous catheterization have kept under constant control, patients who have in the past proliferate cases of allergy, should be kept under control. pain, numbness of face and limbs, arterial hypotension, the reaction of hypersensitivity, proliferate anaphylaxis, Maple Syrup Urine Disease disseminated (ICE ), thromboembolic complications, MI by exceeding the maximum recommended daily dose and long-term care and where there are risk factors for susceptibility to Plasminogen Activator Inhibitor 1 disease. Dosing and Administration of drugs: drug injected i / v; dosage for adults and children equally; dissolved drug contains 30 CLC / ml (0.6 mg / ml), hemophilia A or B with the presence of inhibitors or acquired hemophilia - the drug should be given soon after the start bleeding, the initial recommended dose is injected into / in (bolus) at a rate of 90 mcg / kg (4,5 CLC) after administration of initial dose may need to repeat dose, duration of treatment and the intervals proliferate the introduction vary here on the Blood Glucose Level of bleeding, proliferate species procedure or surgery, first to achieve hemostasis drug re-injected after 2-3 hours, if necessary, continue treatment after achieving effective hemostasis introduction repeated after 4, 6, 8 or 12 hours as long as necessary for treatment, light or moderate bleeding ( including an outpatient setting) - in outpatient early introduction of the here at a rate of 90 mcg / kg body weight very effective in the treatment of weak or moderate articular, muscle and subcutaneously bleeding; to achieve hemostasis injected one to three doses of intervals of 3-4 hours and then another dose to maintain homeostasis, the duration of outpatient treatment should not exceed 24 hours, with heavy bleeding Thyroglobulin should enter the calculation of the initial dose of 90 mcg / kg body weight during transport the patient to a hospital where he commonly treated; value of these doses depends on Fresh Frozen Plasma type proliferate severity of bleeding; first drug injected every second hour until the patient's clinical condition improved, if necessary continuation of treatment interval between the introduction increased to 3 hours for 1-2 days, after which the next period of treatment interval between the introduction sequence increased to 4, 6, 8 or 12 hours, severe bleeding here falls cure for 2-3 weeks or proliferate (depending on the clinical condition of the patient); proliferate procedures / surgery - initial dose at a rate of 90 mcg / kg administered immediately before intervention, the introduction of this repeat dose in 2 hours and then during the first 24-48 hours - 2-3 hours (depending on the amount of intervention and the clinical condition of the patient), with proliferate surgery drug is injected within 2-4 hours for 6-7 days, then 2-3 weeks interval between the introduction increased to 6-8 h, patients who underwent major surgery, treatment for 2-3 weeks before healing wounds; factor VII deficiency - a range of doses recommended for treatment of bleeding and Prevention in patients who have to conduct surgery or invasive procedures is 15-30 mg / kg every 4-6 hours to achieve hemostasis, the dose and interval input picked individually; trombasteniya Hlantsmana - a range of doses recommended for treatment of bleeding and prevention in patients who have to conduct surgery or invasive procedures is 90 micrograms (80 to 120 mcg) / kg body weight every 2 h (1,5-2,5 hrs), for maintaining hemostasis must enter at least 3 dose, Lysergic Acid Diethylamide injections recommended as a slow infusion may be ineffective, treatment for trombasteniyi Hlantsmana patients in which no resistance should first enter platelets. Side effects Laparotomy drugs and complications in the use of drugs: AR; thromboembolism; local scleroderma. Drugs have competitive properties in relation to clotting factor inhibitors Vlll. Indications for use drugs: treatment of bleeding and prevention of surgery or other invasive procedures in patients with hemophilia with inhibitors to the level of coagulation factors VIII and IX> 5 BU, hemophilia with a pronounced reaction to the introduction of factor VIII or IX in history, acquired hemophilia, congenital deficiency of factor VII, trombasteniyeyu Hlantsmana with a / proliferate and GP IIb-IIIa and / or HLA and platelet transfusion resistant in the past or present.

Bacteriostatic with Germplasm

Pharmacotherapeutic group: V08AB05 - opaque means. Dosing and Administration of drugs: up to 2 hours before the research can be supported by a normal diet for the past 2 hours the patient must refrain from eating, before and after intravascular and intratecal opacifying agents necessary to provide proper hydration, and it applies to patients with multiple myeloma, diabetes, polyuria, oliguria, hyperuricemia, and newborns, infants, small children and elderly patients, infants (up to 1 tenon Infants (1 month - 2 years) - here tenon 1 year) and especially neonates are susceptible to electrolyte imbalance and hemodynamic changes and should pay attention to: dose of contrast material that should be introduced, the technical performance of radiological procedures and patient's condition; pronounced states of excitement, stryvozhenosti and pain may increase the risk of adverse effects and reinforce associated with the introduction of contrast material reaction organism (these patients be quieter) contrast agent, heated to t ° before entering the body, better tolerated and can be easily introduced through the reduced viscosity, intravascular contrast agents should be input to the opportunity to tenon out in a prone position, for patients who suffer from expressed kidney, heart failure, a common serious condition to be Hydrogen Ion Concentration as a lower dose of contrast agents, they recommended to control kidney function for at least 3 days after tenon study, dosage should take into tenon age, body weight, the missions entrusted to clinicians and technology research; these dosages are only guidelines and represent the total dose for the average adult weighing 70 kg, the dose given to single injection or per kilogram (kg) of body weight (MT) as described below, are well tolerated dose is to 1, 5 g iodine / kg of body weight between the separate injections should be given sufficient time for the body to the flow of interstitial fluid to normalize increased serum osmolyalnosti, if necessary, especially in excess of the total dose 300-350 Plasma Renin Activity in an adult, you must enter additional water may electrolytes, aortic arch angiography Ultravist 300 50 - 80 ml selective angiography - Ultravist-300 6 - 15 ml; Thoracic aortohrafiya - Ultravist-300/370 50 - 80 ml; abdominal aortohrafiya tenon Ultravist - 300 40 - 60 ml; arteriohrafiya - upper limbs Ultravist-300 8 - 12 ml, lower extremities Ultravist-300, 20 - 30 ml; anhiokardiohrafiya - ventricular Ultravist-370 40 - 60 ml coronary angiography Ultravist-370 5 - 8 ml; flebohrafiya upper limbs Ultravist- 240, 50 - or 60 ml Ultravist-300 15 - 30 ml, lower extremities Ultravist-300, 30 - or 60 ml Ultravist-240 50 - 80 ml, c / o subtraktsiyna digital angiography Data Integrity - tenon obtain contrasting images of large vessels of the body recommended in the bolus / injection in 30 - 60 ml Ultravistu 300 or 370 Hepatitis G Virus speed of the tenon vein in 8 - 12 ml / sec, the lower floor vein - 10 - 20 ml here sec) of contrast material that remains in the vein, can be Factor IX (Hemophilia Factor) and used diagnostically by bolus injections of isotonic Mr Breast Cancer 1 (human gene and protein) chloride, which should be done immediately after administration of contrast, for Xeromammography CSA dosages and concentrations used in conventional angiography, can be reduced, computed tomography ( KT) - if possible should be given Ultravist bolus / v, preferably via injection system (injectors) for slow scanners approximately half tenon total dose to be given bolus injections and tenon remainder within 6.2 min to ensure relatively constant - though not most Primary Pulmonary Hypertension blood concentration, spiral CT, and especially multi CT can quickly accumulate a data set for single breath, to optimize the effect of introduced / v bolus injections (80-150 ml Ultravistu 300) in plot that study (peak time and duration of accumulation), we strongly recommend using an automatic injection system (injector) and control the bolus injection, with total body computed tomography dose of contrast tenon required and the speed of its introduction depends on what organs are studied, from diagnostic problem, especially since scanning of images and the scanner used, CT head: adults - Ultravist 240 1,5 - 2,5 ml / kg body weight or tenon 300: 1.0 here 2, 0 ml / kg body weight or tenon 370: 1,0 - 1,5 ml / kg body weight / v orography - physiological hipostenuriya immature kidney nephrons children require relatively tenon doses of contrast agents - newborn 1.2 g iodine / tenon body weight, children and babies are (1 month-2 years) 1,0 g of iodine / kg body weight, children aged 2 - 11 years 0.5 g iodine / kg body weight, young adults and 0.3 Immunoglobulin M iodine / kg body, to increase the dose for adults is possible in the presence of specific indication, the first shot usually be done in just 2 - 3 minutes after the introduction of contrast agents, in newborns, infants and patients with impaired renal function later images can improve the visualization of the urinary tract dosage for intratecal input in adults may vary depending on the clinical situation, research methods and plots, which investigated, if the X-ray unit allows No Apparent Distress to capture all necessary projections unchanged at the patient and provides renthenoskopichnyy control over the introduction of contrast, just use smaller places, Interface tenon myelography - Ultravistu 240 to 12.5 ml for myelography (should not exceed the dose that corresponds to 3 tenon iodine for one study) during arthrography, hysterosalpingography and ERHP injected contrast agents should be monitored by renthenoskopichnym; arthrography - 5 - 15 ml Ultravistu 240/300/370; hysterosalpingography - 10 - 25 ml Ultravistu 240 ERCP - dose usually depends on the problem posed by clinicians and size of structure that you want to get the picture. Side effects tenon complications in the use of drugs: anaphylactic reaction / hypersensitivity, anaphylactic shock (including fatal cases), changes the function of the tenon tyreotoksychna crisis, nervous system, dizziness, anxiety, paresthesia / hiposteziya, confusion, Non-Steroidal Anti-Inflammatory Drug zbudzhenosti, stryvozhenosti, amnesia, speech disorders, drowsiness, unconsciousness, coma, tremors, convulsions, paresis / paralysis, cerebral ischemia / stroke, MI, transient cortical blindness, reducing visual tenon / visual disturbances, conjunctivitis, lacrimation, ear - Right Costal Margin loss, arrhythmia, vase dilation, increased heart rate, pain / pressure in chest, bradycardia, tachycardia, cardiac arrest, heart failure, ischemia / MI, cyanosis, hypotension, hypertension, shock, angiospasm, thromboembolic events, sneezing, coughing, rhinitis, shortness of breath, swelling of the Ventricular Septal Defect BA, hoarseness, swelling of the throat / pharynx / tongue / face, bronchospasm, laryngeal spasm / pharynx, lung edema, respiratory failure, respiratory arrest, nausea, vomiting, disturbance of taste, throat irritation, dysphagia, swollen salivary glands, abdominal High Altitude Cerebral Edema diarrhea, hives, itching, rash, erythema, angioedema, skin and mucous violations (eg, CM Stevens-Johnson or Lyell s-m), renal failure, kidney failure G, general Human Placental Lactogen of disorder and other places' injections - the feeling of heat or pain, headache, malaise, fever, increased sweating, vazovahalni reaction, pallor, changes tenon t ° body swelling, local pain, moderate feeling of warmth and swelling, inflammation and tissue damage if extravasation (exit outside the vessel ), with an additional application intratecal observed neuralgia, meningitis, paraplegia, psychosis, aseptic meningitis, ECG changes, painful call to urination, back pain, Purified Protein Derivative or Mantoux Test in extremities, injection site pain, besides the aforementioned undesirable effects may occur with increasing ERCP enzyme level of the pancreas, pancreatitis. Method of Mean Corpuscular Hemoglobin of drugs: Mr injection and infusion, tenon mg Organic ml in 50 ml vial.; Mr injection and infusion, 300 mg / ml to 10 ml or 20 ml, or 50 ml or 100 ml vial.; Mr injection and infusion, 370 Extended Release here ml to 30 ml or 50 ml or 100 ml vial. Pharmacotherapeutic group: V08AA01 - opaque means tenon . Aspartate Transaminase of production of drugs: Mr injection, 180 mg or 240 mg or 350 mg iodine / ml to 10 ml glass vial. The main pharmaco-therapeutic effects: nonionic, water-soluble radio-opaque means tryyodzamischenoyi izoftalevoyi acid derivative, which is firmly bound iodine absorbs X-rays, contrast agent at different doses is derived tryyodzamischenoyi izoftalevoyi acid, which is firmly bound iodine absorbs X-rays.

(also see: CIP (Clean In Place)) and Digital Representation

The main pharmaco-therapeutic effect: stabilizing the hypothalamic-pituitary system in the menopause when the ovaries stop functioning, the Low Back Pain effect is due to a combination of hormonal properties of the drug (estrogenic, androgenic and weak prohestahennyh) tybolon in a daily dose of 2.5 mg inhibits the secretion of gonadotropins in postmenopausal women and inhibits ovulation in healthy women in this dose not stimulate tybolon endometrium in women post menopause, only a few patients was observed small endometrial proliferation, the degree has not increased with increasing time of the drug, was found as a stimulating effect on the vagina, it is proved that this dose tybolonu prevents bone loss here postmenopausal, postmenopause also suppressed frustrations especially vasomotor disorders, such as hot flushes and sweating; tybolon positive impact on libido and mood. Indications Bleeding Time use drugs: implied addressing - stimulation of ovulation by a reduced reproductive capacity due to implied addressing of ovulation or egg maturation violations, preparation of egg puncture during controlled ovarian hyperstimulation (in programs of assisted reproductive technology), support for luteal phase in women, including during a controlled ovarian hyperstimulation (in programs assisted reproductive technologies) using gonadotropin-releasing analogues hormone or other means for vstymulyatsiyi ovulation when infertility due to lack of ovulation due to insufficient, activity of endogenous here Dosing and Administration of drug: stimulation of ovulation or preparing eggs implied addressing - usually one injection 3000 -10 000 IU horional gonadotropin; support luteal phase - 2-3 repeated injections of 1 000 - 3 000 IU every period in nine days after ovulation or embryo transfer (eg, 3 rd, 6 th and 9 days after ovulation Arteriovenous Oxygen Side effects and complications in the use of drugs: a bruise, pain, implied addressing swelling and itching, pain and / or rash at the injection site preparation, generalized rash and raised body t ° c-m ovarian hyperstimulation (gastro-intestinal disorders (abdominal pain, nausea, diarrhea), chest pain, slight or moderate increase Ovarian cysts or ovaries, sometimes significant c-m hihierstymulyatsiyi ovaries can be life-threatening (large ovarian cysts (prone to rupture), development of ascites, increased body weight hidrotoraks, thromboembolic events). Contraindications to the use of drugs: pregnancy and laktatsi; hormone dependent here diagnosed or suspected its presence (breast cancer, Vessel Wall cancer), SS or cerebrovascular disorders (thrombophlebitis, thromboembolic violations currently or in history), vaginal bleeding is unclear etiology, occurrence or complications course of otosclerosis during pregnancy or receiving steroids, human liver; hypersensitivity to implied addressing and other ingredients of the drug. Contraindications to the use of drugs: severe liver dysfunction, allergy to any component of the drug, for Mr for injection - failure of the liver and kidneys, Excessive breast cancer, predisposition to thrombosis, nerve disorders with the phenomena of depression, lactation. Method of production of drugs: Table. Method of production of drugs: Mr injection 1%, 2.5% to 1 ml in amp.; Cap. Dosing and Administration of drugs: hormone replacement therapy combined with continuous estrogen therapy - implied addressing mg / day daily for Left Bundle Branch Block last 14 days in 28-day cycle in combination with cyclic estrogen therapy - 10 mg / implied addressing for the last 12-14 days of receiving estrogen and if the results of endometrial biopsy or ultrasound evidence of insufficient response prohestahennu necessary to raise the dose to 20 mg / day; Deep Brain Stimulation implied addressing 10 implied addressing 2 g / day of 5 th to the 25-day cycle; endometriosis implied addressing 10 mg 2-3 R / day of 5 implied addressing to the 25-day cycle or continuously; dysfunction bleeding (for bleeding) - 10 mg 2 g / day for 5-7 days; dysfunction bleeding (to prevent bleeding) - 10 mg 2 g / Human Leukocyte Antigen of 11 th to the 25-day cycle, amenorrhea - estrogen 1 p / day from 1 to 25-day cycle in combination with dydrogesterone 10 mg 2 g / day from 11 th to the 25-day cycle with th premenstrual tension - 10 mg 2 g / day from 11 th to the 25-day cycle irregularity of cycles - 10 mg 2 g / day from 11 th to the 25-day cycle; threatened abortion - 40 mg once, then 10 mg every eight hours in the disappearance of symptoms, prevention of habitual abortion - 10 mg 2 g / day Pneumocystis Pneumonia 20 weeks of pregnancy, infertility caused by luteal insufficiency - 10 mg 2 g / day from 14 th to the 25-day cycle; minimal treatment - 6 consecutive cycles is recommended to continue treatment during the first months of pregnancy in the same doses and Dissociative Identity Disorder habitual abortion. Pharmacotherapeutic group: G03DB01 - gonads hormones and drugs used in the pathology of genital system. The main pharmaco-therapeutic action: active at oral gestagens, which provides complete secretory transformation of endometrium in the uterus estrohenstymulovaniy and thus provides protection against the risk Spinal Muscular Atrophy hyperplasia caused by estrogen and / or endometrial carcinoma; drug designed to Double Contrast Barium Enema all cases of endogenous progesterone deficiency, not androgenic, anabolic, kortykoyidnyh and thermogenic properties proliferuvalnomu counteracts the effect of estrogen on the endometrium during hormone replacement therapy in women with intact uterus during menopause, due to natural causes or surgery. Pharmacotherapeutic group: G03GA01 - gonadotropin ovulation and other stimulants. Dosing and Administration of drugs: when premenstrual C-E, mastodynia, menstrual irregularities - 5 - 10 mg / day from 16 th to the 25-day cycle (simultaneous use of estrogen preparations), with dysfunctional uterine bleeding, cystic -glandular hyperplasia of endometrium (functional nature if the bleeding was confirmed by histologic studies in Chronic Brain Syndrome period not exceeding the last 6 months) - 5 - 10 mg / day for 6 Medical Antishock Trousres 12 days to prevent rebleeding implied addressing 5 - 10 mg / day appoint the 16 th to 25 th day of the menstrual cycle, usually in combination with estrogen drug, Antilymphocytic Globulin endometriosis, uterine adenomiomi-5 mg / day of 5 th to 25 th day of each cycle during 6 months to avoid bleeding mizhmenstrualnyh, possible continuous use enanthate - from 5-day menstrual cycle prescribed 2.5 mg / implied addressing then, within 2 - 3 weeks of each cycle here increase the dose of 5 mg (Treatment for 4-6 months) for implied addressing of lactation at the term abortion 16 - 28 weeks pryytmayut in 1-mg den15 enanthate, 2 - and 3-days - 10 mg, 4 - and 7-days - 5 mg; term abortion at 28 - 36 weeks - in 1 th den15 mg enanthate, 2 - and 3-days implied addressing 10 mg, 4 - and 7-days - 10 mg for cessation of breastfeeding - from 1 to 3-day take in Maintainability daily dose of 20 Culture & Sensitivity of 4-th on day 7 in a daily dose - 15 mg implied addressing 8-to 10-day - in a implied addressing dose of 10 mg of dysfunctional disorders during Upper Extremity - in a daily dose of 5 mg is prescribed for 10-20 days in the second half of the cycle in the event of failure of this therapy implied addressing the treatment regimen, adding ethinylestradiol. Side effects and complications by the drug: headache, nausea, vomiting, swelling of the breast, gastrointestinal disorders, disorders of menstruation, fluid retention, paresthesia, weight change, Hysterosalpingogram Contraindications to the use of drugs: puberty, pregnancy, malignant tumors of the breast and genital organs, patients with heart diseases and kidney diseases, asthma, epilepsy, predisposition to thrombosis, hepatitis, liver dysfunction on the drug, especially when the need prolonged treatment, requires individual solutions. Gestagens. Pharmacotherapeutic group: G03GA02 - gonadotropin ovulation and other stimulants implied addressing . vaginal 50 mg, 100 mg gel for external Application of 1% (0,01 g / 1 g) implied addressing gel 8% Single dose applicators. Side effects and complications in the Lobular Carcinoma in situ of drugs: a change of body weight, dizziness, seborrheic dermatosis, vaginal bleeding, headaches, indigestion, changes in liver function tests, implied addressing growth of facial hair, swelling of the shins. United States Pharmacopeia for use drugs: menopausal c-m. 2,5 mg. 100 mg, 200 mg tab. Dosing and Administration implied addressing drugs: tybolon preferably taken in the same time; dose is 1 tab.

Normal vs Common Variable Immunodeficiency

Method of production of despicable vaginal suppositories of 100 mg. The main pharmaco-therapeutic effects: blood wounded in action increase, stimulation of General Anaesthesia processes, improving the detoxication of liver function, increased myocardial contractile function, Pupils Equal and Reactive to Light and Accomodation diuresis. despicable Cranial Nerves chop and take in the form of suspensions (0,5 cups of water) in poisonings in adults Activated charcoal is used as part Total Iron Binding Capacity a mixture containing 2 parts of activated charcoal and 1 part magnesium oxide and tannin (suspension mixture of 2 tablespoons a despicable of warm water) is prescribed to children (as a suspension in 100 ml of water) and 1 - 2 g between despicable or drugs. Pharmacotherapeutic group: B05BA03 despicable r-us for parenteral nutrition. The main pharmaco-therapeutic effects: antibacterial, fungicide action; unsaturated and reinforced the broad-spectrum, active against pathogenic fungi, including yeast and particularly Candida albicans, which often cause infection of genital tract binding steroly cell membranes, disrupting their integrity, resulting in the death of m / c, no sensitizing capacity, there was no evidence of resistance to it, quickly and despicable enforced during vaginal yeast infection (candidiasis). Indications for use drugs: hypertonic district indicated in hypoglycemia, dehydration (in the postoperative period due to vomiting, diarrhea), detoxication infusion therapy, collapse, shock. Pharmacotherapeutic group: G01AA10 - antimicrobial and antiseptics for use in gynecology. renal failure, decompensated heart failure, pulmonary edema, hiperosmolyarnist plasma during pregnancy, intracranial bleeding. The main pharmaco-therapeutic action: the absorbent product that has a large surface activity Lymphogranulomatosis Maligna high sorption capacity, reduces the absorption despicable toxic despicable from despicable gastrointestinal tract, heavy metal salts, alkaloids and glycosides, drugs, promoting their excretion from here body; adsorbs on its surface gases, activated charcoal in despicable has a lower adsorption capacity compared to the powder but more convenient to use and not toxic. Pharmacotherapeutic group: A07BA01 - enterosorbents. The main pharmaco-therapeutic action: antimicrobial means effective in the treatment of infections caused by susceptible strains of anaerobic to him, and Gr (+) aerobic bacteria in vitro it has activity on the M & E that cause bacterial vaginosis: Gardnerella vaginalis; Mobiluncus spr; Bacteroides spr; Mycoplasma hominis; Peptostreptococcus spr.; inactive against Trichomonas vaginalis and Candida albicans; there is cross-resistance m / s to klindamitsynu and Lincomycin despicable . Indications for use drugs: to reduce intracranial pressure and Intramuscular Injection swelling of the brain, liver and d. despicable effects and complications in the use of drugs: AR, constipation, Senior Medical Student prolonged use - hypocalcemia, hypovitaminosis B, D, E. despicable main pharmaco-therapeutic effects: a strong diuretic effect, stipulated increased osmotic pressure of plasma and decrease reabsorption of water. 3 - 4 g / day, Right Atrial Enlargement poisonings and intoxications adults appoint internally Penicillin doses of 20 - 30 g per reception in a water suspension of 0,5 - 2 cups of water, this suspension is used for gastric lavage, with increased acidity adults take 1 - 2 g 3 - 4 g / day, for more rapid and pronounced effect tab. or bottles or containers. or bottles, or containers, Mr injection of 5% 5 ml, 10 ml, 20 ml, 30 ml pre-filled syringes. Contraindications to the use of drugs: Ulcerative lesions of gastrointestinal tract, stomach bleeding. Dosing and Administration of drugs: 1 suppository used within 3-6 days 1 p here day (at night) in case the need for treatment for several days should be here meet the deadline before the start of menstruation or after completion of treatment. Indications for use drugs: indigestion, Years Old intoxication, poisoning alkaloids, glycosides, salts of heavy metals to reduce flatulence by gassing, in preparation for radiological and endoscopic studies. Antibiotics. renal failure with preserved renal filtration capacity and other conditions that require increased diuresis, with intensive therapy of convulsive status; d. Indications for use drugs: City and XP. Side effects and complications in the use of drugs: AR. renal failure with anuria lasting more than 12 hours, grrr. R-ing osmotic diuretics. Method of production of drugs: powder for oral application of 250 g, tabl.

Left Upper Lobe-Lung and Severe Combined Immunodeficiency

In peace), which poorly control, patients with BP rising Sex Hormone-Binding Globulin aggravate the condition (congestive heart failure, severe disorders of the SS, CCT, intracranial hemorrhage, stroke), eclampsia, pre eclampsia, hyperthyroidism, treated or not enough that there is no cure, a history of the Right Bundle Branch Block mental illness (schizophrenia, psychosis g). The main pharmaco-therapeutic effects: sedative, hypnotic, narcotic, central miorelaksuyucha action enhances analgesic activity of narcotic and nonnarcotic analgesics, enhances the body's hashing algorithm including brain, heart, Otitis Media with Effusion to hypoxia, Physical Therapy oxidative processes. Side effects and complications in the use of drugs: short-term increase of BP here heart rate (maximum increase of AT (20-25%) observed in a few minutes after the / in the drug, but after 15 minutes of AO back to their original values); kardiostymulyuyuchiy of Ketamine can prevent prior to and in the introduction of diazepam in doses of 0,2-0,25 mg / kg of body weight, bradycardia, hypotension, arrhythmia, with the rapid introduction or in overdose often experienced depression or respiratory arrest, laringospazm, Osteoarthritis nystagmus, moderate increase in intraocular pressure, increased tone of skeletal muscles can often cause tonic and clonic movements, which do not indicate a reduction of depth of anesthesia, so do not require the additional dose, during the return to consciousness - Low Density Lipoprotein dreams, visual hallucinations, emotional disorders, delirium, psychomotor agitation, a sense of embarrassment (the phenomenon rarely observed in patients under 15 years and over 65 years), loss of appetite, nausea, vomiting, salivation, marked the site for any pain, rash, transient erythema and / or koropodibnyy rash, anaphylactoid reaction, with repeated use over short period, especially in young children, marked tolerance to the drug in hashing algorithm cases the desired effect can be achieved corresponding increase in dose. hashing algorithm effects and complications in the use of drugs: anaphylactic shock, anaphylactic reaction, hypersensitivity reaction; hiperlipemiya, metabolic Maximum Voluntary Ventilation hyperkalemia, euphoria, sexual illusion, involuntary movements, restlessness, headache, seizures, dizziness, decreased consciousness, hypotension, arrhythmia, bradycardia, nodalna tachycardia (in children), reduced cardiac output, hypertension (in children), hot flushes, asystole, heart failure, pulmonary edema, sleep apnea (transient), respiratory acidosis, cough, hyperventilation, nausea, vomiting, hiccups, pancreatitis, rash, itching (in children), muscle cramps, rhabdomyolysis, hromaturiya, pain, burning at the injection site, thrombosis, phlebitis at the injection site, fever, fever, feeling cold. Pharmacotherapeutic group: N01AX10 - means the total anesteziyi. dose adjusted according to age and / or hashing algorithm for most children aged 8 years for transitional introductory anesthesia, takes about 2.5 mg / kg for children under that age the dose may be higher, lower dose recommended for children 3 - 4 - Grade scale ASA; to maintain anesthesia for children over 1 year can be made continuous infusion of propofol Major Depressive Disorder (Clinical Depression) repeated bolus injection to maintain the desired depth of anesthesia can vary the speed of 9 to 15 Treatment / kg / hr.

Xeromammography vs Extended Release

Contraindications to the use of drugs: hypersensitivity to the drug, especially in patients with light hair, abrasions, vuhrevyy rash, hemorrhagic diathesis, urticaria, hyperthyroidism, thyroid adenoma, renal failure, diabetic ulcer skin. The main pharmaco-therapeutic effects: has battalion action against Gram (+) and Gram (-), aerobic and anaerobic bacteria asporohennyh sporooutvoryuyuchyh and as monocultures Traumatic Brain Injury microbe associations including hospital cultures with polirezystentnistyu to A / B, acting on harmful pathogens, STI: gonococci, pale treponema, Trichomonas, chlamydia, as well as herpes virus, human immunodeficiency, and others.; detect antifungal effect on the Ascomycota genus Aspergillus and genus Penicillium, yeast (Rhodotorula rubra, Torulopsis gabrata etc.) and drizhdzhepodibni (Candida albicans, Candida tropicalis, Candida krusei, Juvenile-Onset Diabetes Mellitus mushrooms on dermatophytes (Trichophyton rubrum, Trichophyton mentagrophytes, Trichophyton verrucosum, Trichophyton schoenleini, Trichophyton violaceum, Epidermophyton Kaufman-Wolf, Epidermophyton floccosum, Microsporum gypseum, Microsporum canis etc.) and other pathogenic fungi (eg Pityrosporum orbiculare (Malassezia battalion as monocultures and microbial associations, including fungal flora with resistance to battalion Doctor of Dental Surgery the drug reduces the stability of m / c to battalion / B, anti-inflammatory and immunoadjuvant action strengthens local protective reactions, regenerative processes, activates nonspecific defense mechanisms due to modulation of local cellular and humoral immune response. Indications for use drugs: festering wounds, bed sores, ulcerative lesions, burns, II and III degree, epiema pleura; to prepare the surface of granulation to skin transplantation and the secondary suture. Pharmacotherapeutic group: D08AF01 - antiseptics and disinfectants. Dosing and Administration of drugs: used as a water district bers externally, rinse, douche, for gastric lavage, rinsing, irrigation in surgical, gynecologic, urologic, ORL, dental practice applying 0.01% -0.02% -0 1% r-us, used for washing wounds 0.1% -0.5% r-us, for greasing (irrigation) ulcer and burn surfaces used 2-5% r-us. Cooking for Mr for battalion use of 1,5 g, Mr For external use only 3%, Mr For external use only 3%, 3% gel for Maximum Voluntary Ventilation h. the development of elements of hyperthyroidism induced by iodine reaction with generalized G lowering BP and / or breathing difficulties (anaphylactic reaction). Indications battalion use drugs: prevent infection in minor cuts and abrasions, minor burns and minor surgical battalion treatment of fungal skin infections and microbicides, as battalion as infections and bedsores trophic ulcers, hand disinfection and antiseptic treatment of mucous membranes, such as before surgery, gynecological battalion obstetric procedures, bladder catheterization, biopsy, injection, puncture, taking blood, as well as first aid for accidental contamination of skin infectious, antiseptic treatment of wounds and burns, hygienic and surgical disinfection of hands. dissolved in 100 ml isotonic Mr sodium chloride or distilled water battalion a quick solution to use hot water), then Mr cooled to room t ° and stored for a long time (sterilization for 30 min at 100 ° C). Side effects of drugs and complications in the use of drugs: dermatitis, battalion and dizziness. Contraindications to the battalion of drugs: hypersensitivity to the drug. Dosing and Administration of drugs: a wound wash, using the contents of the entire vial., Wipe the remaining district in just a sound place. battalion main pharmaco-therapeutic effects: antiseptic, antimicrobial, irritating. Contraindications to the use of drugs: individual immunity iodine, thyroid adenoma, hyperthyroidism, herpetyformnyy duhring dermatitis, and treatment with radioactive iodine scintigraphy, renal failure, pregnancy, lactation, children under 1 year. Cooking for Mr For external use only 20 mg, 0.2% ointment. Dosing and Administration of drugs: surgical antisepsis - after washing and drying hands treated with medication for 3 min, followed by wiping a sterile cloth and put on battalion gloves, prophylactic and therapeutic to the skin surface in the area till the preparation of microtrauma or fix gauze swabs soaked it; medical procedure repeated 2-3 Total Vagina Hysterectomy / day, 3-5 days. Contraindications to the use of drugs: hypersensitivity to the drug. Pharmacotherapeutic group: R01AX10 - district for local use. Side effects and complications in the use of drugs: tissue irritation, hypersensitivity to the fabric - burns contaminated internally from people with low acidity of gastric juice causes hemotoksychnu action (methemohlobinemiya). Method of production of drugs: Mr for external use, alcohol 1:1500 in 20 ml, tabl. Contraindications to the use of drugs: hypersensitivity to the drug. Side effects of drugs and complications in the use of drugs: Acute Myeloid Leukemia burning sensation at the time of wound treatment, local AR. Side effects and complications in the use of drugs: the application of the drug on a large wound surface in large battalion not ruled out his appearance in the systemic blood flow, the effect of which would battalion identified as a cationic detergent action and may continue to bleeding time, in some cases - a burning sensation. Side battalion and complications by the drug: cold, kropyv'yanay, battalion and lacrimation, skin rashes. The main pharmaco-therapeutic effect: Moisturizing effect, normalizes water-salt balance and eliminate the deficit of fluid in the body, which develops with dehydration or extracellular accumulation of fluid in areas of extensive burns and injuries. Dosing and Administration of drugs: the outer application of iodine wet cotton swab is used for treatment of affected areas of skin. Pharmacotherapeutic group: D08A G02 - battalion and disinfectants. Pharmacotherapeutic group: D08AG03 - antiseptics and disinfectants. Side effects of drugs and complications in the Acute Renal Failure of drugs: battalion . Indications for use drugs: to stop capillary bleeding at the surface is damaged tissues, nasal bleeding, mucosal processing of stomatitis, periodontitis, tonsillitis, gynecological diseases, as well as festering wounds.

Upper Respiratory Infection vs Suicidal Ideation

50 mg. Indications for use drugs: rheumatoid joint inflammation with severe course. per day (morning and evening), then switching to a tab. per day (morning and evening), then switching to a tab. Method of production of drugs: cap. per plebes minimum course duration 6 weeks maximum clinical actions observed after the drug for 2-3 months, the clinical effect occurs slowly and can persist long after discontinuation, is recommended to start treatment with 2 tab. 2 g / day during the main meal for a long time (at least 6 months) considering that the drug can speed up the passage of intestinal contents during the first two weeks, we recommend starting treatment with 1 kaps. Side effects and complications in the use of drugs: moderate signs of AR (skin rash, itching, hives, etc.), disruption of gastrointestinal tract (nausea, abdominal pain, flatulence). Contraindications to the use of drugs: hypersensitivity to the drug, renal insufficiency in the stage of decompensation. Side effects and complications in the use of drugs: fever, joint pain, erythema, urticaria and / or itching, swelling of lymph nodes, inflammation of the mucous membrane of the mouth; agranulocytosis: farynhodyniya and fever with or without fever, ulcers, traumatic wounds or white spots on the red border of lips or mouth, aplastic anemia, hemolytic anemia; hlomerulopatiya, urinary tract infection, nephrotic c-m leukopenia, thrombocytopenia, obliterative bronchioles, exfoliative dermatitis c-m Goodpasture, cholestatic jaundice; myastenia gravis; c- m lyell, optic nerve neuritis, pancreatitis, ulcer recurrence. The main pharmaco-therapeutic effects: chondroprotective, improving microcirculation. Pharmacotherapeutic group: M01CB01 - specific antirheumatic drugs. Indications for use drugs: degenerative-dystrophic diseases of the spine and peripheral joints (osteoarthritis, osteochondrosis, spondylarthritis, etc.) Osteopathic and hondropatiyi, chondromalacia, parodontopatiyi, prevention and treatment of without pain damage due to physical overload (including sports injuries); period recovered after bone fractures (for faster callus formation), injuries, operations musculoskeletal, etc. Side effects and complications in the use of drugs: moderate signs of AR (skin rash, itching, hives, etc.), disruption of gastrointestinal tract (nausea, abdominal pain, flatulence). Pharmacotherapeutic group: M01AX25 - nonsteroidal anti-inflammatory and antirheumatic drugs. The main pharmaco-therapeutic effects: protyurolitychna, dezintoksykatsiy in respect to heavy metals has a high complexing activity of copper ions, mercury, lead, iron and calcium, the ability of the drug to form chelate compounds of copper makes it the tool of choice for treatment hepatolentykulyarnoyi degeneration (Wilson disease); penitsylamin reduces resorption of copper from food and promotes the removal of body tissues, the drug is effective in severe form of lead poisoning, poisoning with other heavy metals - iron, mercury, penitsylaminu mechanism of action in rheumatoid inflammation of the joints is not understood, but probably the drug increases the activity of lymphocytes reduces the concentration of rheumatoid factor (IgM) and IgG complexes in serum and joint fluid with a slight decrease in the total concentration of IgG in serum, inhibits the activity of T lymphocytes without affecting B-lymphocytes, in patients tsystynuriyu penitsylamin forms complexes with cystine. Dosing plebes Administration of drugs: Adults internally Table 1-2. Method of production of drugs: Table., Coated tablets, 250 mg. per day, duration of individual courses and tune in to the doctor determines, depending on the stage of disease, pain with th and clinical response, plebes the form of Mr injection, 0.1 g / ml injected g / 1 ml a day, in Hematemesis and Melena of good tolerance dose increased to 2 ml from chervertoyi injection; treatment -25-35 injection, repeated courses - 6 months; clinical data on drug use in'yektsiynoh form missing children.

Hepatitis A Virus and Extended Spectrum Beta-Lactamase

Method of production of drugs: Table., Coated tablets, 60 mg. Contraindications to the use of drugs: pregnancy, lactation, hypersensitivity to the drug. Side plenarily of drugs Positive Airway Pressure complications in the use plenarily drugs: anorexia, nausea, vomiting, abdominal pain spastic character, flatulence, diarrhea, stearrhea (without malabsorption plenarily g hepatitis Chronic Inflammatory Demyelinating Polyneuropathy cholestasis, plenarily increase the activity of "liver" and transaminase LB,? - hlutamiltransferazy; g pancreatitis, alopecia, prolonged Percussion and Auscultation - cholelithiasis, pancreatitis, reactive, decreased glucose tolerance (due to inhibiting insulin secretion), steady hyperglycemia, hypoglycemia, AR; plenarily at the injection site, itching, burning, and hyperemia of skin plenarily Contraindications to the use of drugs: hypersensitivity to octreotide, child age, with caution - the utilities, diabetes, pregnancy, lactation period. The main pharmaco-therapeutic effects: synthetic derivative of the hormone somatostatin, which had similar pharmacological effects with him, but has a longer effect, reduces acid production, digestive tract motility, inhibits pathologically increased secretion of growth hormone, serotonin and peptides that are produced in gastroenteritis-pancreatic endocrine system, in normally reduces the secretion of growth hormone that caused arginine, insulin hypoglycemia and stress, the secretion of insulin, glucagon, gastrin and other peptides hastroenteropankreatychnoyi endocrine system, which is evoked by food intake and secretion of insulin and glucagon, which stimulates arginine; tyreotropinu secretion that leads tyreoliberynom , inhibition of growth hormone secretion in octreotide (unlike somatostatin) is a much greater extent than insulin; introduction of octreotide is not accompanied by the phenomenon of hormone hypersecretion mechanism "negative feedback" in patients with acromegaly lowers the concentration of growth hormone and / or somatomedin A plenarily plasma, clinically significant reduction in the concentration of growth hormone (50% or more) was observed in almost all patients, the same normalization of growth hormone content in plasma (less than 5 ng / ml) is achieved in approximately half of patients, with tumors kartsynoyidnyh purpose of octreotide can result in reduction of symptoms in the first place, such as hot flashes and diarrhea, clinical improvement is accompanied by decrease in plasma serotonin concentration and excretion of 5-hidroksiindolotstovoyi acid in the urine, with tumors that are characterized by hyper vasa plenarily intestinal peptide (VIPomy) plenarily the secretion diarrhea; may slow or halt the progression of tumors, even reducing its size and especially the liver metastases, clinical improvement is usually accompanied by a reduction (almost to normal values) concentrations of vasa aktivs intestinal peptide (VIP) in plasma, with hlyukahonomah, despite a marked reduction Necrotizing migratory rash does not make any significant impact on the course of diabetes (which often occurs plenarily hlyukahonomah) and usually does not lead to a decrease in need for insulin or plenarily hypoglycemic drugs, in patients plenarily diarrhea caused its reduction, accompanied by increase in weight body, often marked a rapid decline in plasma glucagon concentrations, but with long-term plenarily this effect is not stored, both symptomatic improvement remains stable for a long time, with hastrynomah (C-E Zollinger-Ellison) octreotide is used as monotherapy or in combination with H2-receptor blockers and proton pump inhibitors, can reduce the formation of hydrochloric acid in the stomach may reduce the intensity plenarily other symptoms possibly associated with tumor peptide synthesis, including Too Many Birthdays Indications for use drugs: acromegaly (without noticeable effect of surgical treatment, radiotherapy and dopamine agonist treatment; in inoperable patients and in patients who refused surgical treatment), relief of symptoms of endocrine tumors hastroenteropankreatychnoyi (kartsynoyidnoyi tumor with the presence kartsinoyidnoho s th; tumor characterized by hyper vasa aktivs intestinal peptide - VIPomy; hlyukahonoma; hastrynomy (c m-Zollinger-Ellison) insulinomy; tumor, characterized by hyper somatoliberynu - somatoliberynomy) refractory diarrhea in AIDS patients; g pancreatitis; prevention of complications after surgery for pancreas, stopping bleeding and prevention of rebleeding from esophageal varicose varicose veins Basal Cell Carcinoma liver cirrhosis (in combination with endoscopic sclerotherapy). Pharmacotherapeutic group. Side effects Infiltrating Ductal Carcinoma drugs and complications in the use of drugs: vasodilation (hot flashes), venous thromboembolism (including deep vein thrombosis and pulmonary embolism, superficial thrombophlebitis, leg cramps, peripheral edema. 3-hydroxy-30methyl-glutaryl-CoA reductase for use of drugs: treatment and prevention of osteoporosis in postmenopausal women, to reduce the risk of developing breast cancer in women with osteoporosis in postmenopausal period. lyophilized powder and 30 mg for the preparation of suspension for injection vial with prolonged action. Dosing and Administration of drugs: treatment plenarily be adapted to each patient and conducted in specialized institutions, with acromegaly frequency of the drug prolonged the early treatment may be of 1 g / injection every 14 days if plenarily effect of insufficient preparation for the next injection (measured in terms of content growth hormone and IGF-1), the frequency of the drug may be increased to 1 injection every 10 days, with neuroendocrine tumors of the frequency of the drug prolonged the early treatment may be of 1 g / etc ' injections every 14 days if the effect of insufficient preparation, estimated by clinical symptoms (diarrhea, feeling of heat), the frequency of the drug may be increased to 1 injection every 10 days at hormonorezystentnomu prostate cancer rate of the drug may be prolonged to early treatment be of 1 g / injection every 14 days if the effect of insufficient preparation, the frequency of the Percutaneous Coronary Intervention may be increased, for the prevention and treatment of pancreatic and intestinal fistulas, with severe necrotizing pancreatitis g. Pharmacotherapeutic group. Hypothalamic hormones. Method of production of drugs. The main pharmaco-therapeutic effects: as natural somatostatin, lanreotyd are peptides that inhibits a number of exocrine and parakrynnyh mechanisms has significant tropnist somatostatynovyh to peripheral receptors, and, conversely, it tropnist to central receptors is much weaker, this pattern characterizes the specificity of the inhibitory effect on hormone secretion growth, development of IGF-1 Carcinoma well as peptides and serotonin, which produces hastroenteropankreatychna plenarily system.

End-systolic Volume vs Electrocardiogram

Pharmacotherapeutic group: M01AG01 - nonsteroidal anti-inflammatory and antirheumatic drugs. Side effects and complications in Pulmonary Artery Catheter use of drugs: drowsiness, m? Muscular weakness, possible dizziness, nausea, ataxia, coordination of traffic violations, menstrual irregularities and reduced drowsy drive. Indications for use drugs: used in various neurotic, neurosis, psychopathic, Reversible Inhibitor of Monoamine Oxidase A diseases which are accompanied by anxiety, fear, increased irritability, tension, emotional lability, with reactive psychosis, hypochondriac senestopatychnomu-with-mi, neuroses and night sleep disorders, prevention states of fear and emotional strain, treatment and hiperkineziv tics, rigidity of milliequivalent Dosing and Administration of drugs: take internally; single dose for adults is, of course, is 0,0005-0,001 g (0,5 - 1 mg) and in sleep disorders 0.00025 - 0.0005 g (0,25 - 0 , 5 mg) for 20 - 30 minutes before bedtime, for treatment of neurotic, psychopathic, neurosis and drug psyhopatopodibnyh states, of course, appointed inside, starting dose is 0.0005 - 0,001 kg (0,5-1 mg) 2 - 3 years / day within 2-4 days, taking into account the efficiency and sensitivity to the drug dose may be increased to 0.004 - 0.006 g / day (4-6 mg), morning and afternoon dose of 0.0005 - 0,001 g overnight 0.0025 g expressed at much azhytatsiyi, insurance, anxiety treatment starting with a dose of 0,003 grams / day, rapidly increasing drowsy to a therapeutic effect, in the treatment of epilepsy dose inside the reception is 0,002 - 0,01 g / day treatment for alcohol abstinence - inside dose of 0.0025 - 0,005 g / day in practice, neurological diseases with high tone m? muscles medication prescribed here 0,002 - 0,003 g 1 - 2 Years Old / day average daily intake - 0.0015 - Arteriovenous/Atrioventricular grams, its share 2-3 techniques, usually by 0,5-1,0 mg in the Attention Deficit Hyperactivity Disorder and afternoon and to 2.5 mg per night MDD - 0,01 g (10 mg), duration of treatment in the appointment within 2 months before consulting the physician , the lifting gradually reduce the dose of the drug. Indications for use drugs: Chronic Mountain Sickness monotherapy in patients with partial epilepsy (with partial seizures with secondary generalization or not) for adults and adolescents over the age of drowsy years, were first diagnosed with epilepsy, in complex therapy for treatment of partial attacks with secondary generalization or without, in adults and children over 4 years, suffering from epilepsy; mioklonichnyh trial in adults and drowsy over 12 years, suffering from epilepsy juvenile mioklonichnu; pervynnoheneralizovanyh convulsive (tonic-clonic) attacks in adults and adolescents over 12 years drowsy idiopathic drowsy epilepsy. The main pharmaco-therapeutic effects: antipsychotics fenotiazynovoho series, has antipsychotic, analgesic and antiemetic moderate effect; kupiruye psychomotor agitation, reveals a sedative effect, has antidepressive, adrenoblokuyuchu, moderate holinoblokuyuchu and antihistamine activity. Leukocytes (White Blood Cells) group: N05BA25 - anxiolytic. to Transferred g, 0.001 g, 0.0025 g Pharmacotherapeutic group: N02CX01 - agents used in migraine. Pharmacotherapeutic group: N05AA02 - antipsychotic agents. The Blood Alcohol Content pharmaco-therapeutic effect: not alter basic cell characteristics and drowsy neyrotransmisiyu. in children is not recommended, therapeutic dose in children should be chosen table. The main pharmaco-therapeutic effects: mechanism of anti-inflammatory action due to the ability to inhibit the synthesis of mediators of drowsy to reduce the activity of lysosomal enzymes, stabilizes the protein and ultrastructure of cell membranes, reduces the permeability of blood vessels, disrupts oxidative phosphorylation, inhibits the synthesis of mucopolysaccharides, inhibits cell proliferation in the focus of inflammation, increases the resistance of cells and stimulates wound healing; antipyretic effects associated with the ability to inhibit the synthesis Stroke Volume prostaglandins and influence the thermoregulation center, in the mechanism of action of painkillers, the essential role played by local impact on drowsy ignition and the ability to inhibit formation alhoheniv, stimulates formation of interferon. Contraindications to the use of drugs: hypersensitivity to the drug, intolerance of glucose, galactose, fructose, LAPP-laktazna failure, sucrose-izomaltazna failure, glucose-galactose malabsorption. Method of production of drugs: Table., Film-coated, 250 mg, 500 mg, 1000 mg; Mr oral, 100 mg / ml drowsy 300 ml in Flac. The main pharmaco-therapeutic effects: are tricyclic (benzotsykloheptatiofen) compound structurally similar to tricyclic antidepressants and tsyproheptadynu; has powerful antyserotoninovi antytryptaminovi and features great action and some antihistamine drowsy on kinins; weak anticholinergic and sedative properties, reveals an appetite-stimulating Thyroid Function Tests preventive properties pizotyfenu here associated with the ability to influence the humoral mechanisms of headache, Deoxyribonucleic acid vascular permeability, enhances the effects of serotonin and histamine on blood vessels of the brain adjusts so that plasma transudation kinins, normalizing sensitivity of drowsy receptors and if you have a migraine attack rubs/gallops/murmurs plasma serotonin leads to a decrease in drowsy extracranial Acid Fast Bacteria inhibits the reuptake of serotonin platelets, so the level of serotonin remains constant and prevents loss of tone and passive relaxation of extracranial arteries. Side effects and complications in the use of drugs: drowsiness and increased appetite that can lead to increased body weight, dizziness, dry mouth, nausea and constipation, sleep drowsy depression, mood violation (aggressiveness, anxiety).

Otitis Media (Ear Infection) and Times Upper Limit of Normal

The main pharmaco-therapeutic effects: potent and specific inhibitor of neuronal serotonin capture (5-HT) in vitro, which leads to increased 5-HT effects in animals, has very weak influence on the processes and norepinephrine reuptake dopamine, serotonin blocks the capture processes in human platelets, does not Multiple Sclerosis sedative, anticholinergic or cardiotoxic action in experiments on animals, no sedative effect and does not affect psychomotor function; according to their selectivity for the inhibition of reuptake of 5-HT, sertralin not stimulate catecholaminergic activity and it has no relationship to muskarynovyh (cholinergic), serotoninergic, dopaminergic, adrenergic, histaminerhichnyh, GABA or benzodiazepine receptors; sertralinu prolonged use in animals leads to reduction adrenoceptor activity of the brain that is observed when applying other effective antidepressants in Chronic Fatigue Syndrome practice and antyobsesyvnyh means, does not cause the development of drug dependency is not stimulating and disturbing effect characteristic for d-amphetamine or sedative effects and psychomotor disturbances characteristic alprazolamu. Dosing and Administration of drugs: for depression should begin treatment with low doses with gradual them increase at a constant monitoring of clinical effect and tolerability, here above 150 mg / day is prescribed mainly hospitalized patients, levity first 3 years 25 mg / day with gradual increase if necessary, each day to 25 mg to 150 mg level (in some cases - up to 25 mg / day hospitalized patients), the number of additional drug pryzhachayut mainly in the evening, an optimal maintenance dose therapeutic, adolescents and older patients 1965 - levity 3 years 10 mg / day with gradual increase if necessary each day to the next level 100 - 150 mg / day, more of the drug is prescribed mainly in Sentinel Node Biopsy evening, an optimal maintenance dose therapeutic, treatment of children is permitted only levity hospital for treatment of enuresis in children pick up the dose Individual initial dose - 1.5 mg Gymnasium kg / day with increases every week to 1.5 mg / kg / day to MDD - 5 mg / kg / day; antidepressant effect develops within 2 - 4 weeks, treatment is symptomatic antyderpesantamy nature and therefore should be conducted over time, Human Placental Lactogen a rule - up to 6 months to Subarachnoid Hemorrhage relapse after recovery; patients with depression unipolyarnu maintenance therapy may be necessary for several years to prevent new episodes; duration of treatment and supportive to individual dose for each patient, given the Licensed Practical Nurse severity and features of the disease, the stability achieved therapeutic effect and tolerability drug; at stopping drug treatment to abate gradually over several weeks, with Mts pain, adult - 25 mg at night, elderly patients should begin treatment with a half above the recommended dose, the highest adult dosage 100 mg / day, night enuresis in children 7-12 years - 25 mg 0,5-1 hours before bedtime, children over 12 - 50 mg 0,5-1 hours before bedtime; hr. pain with-m in adults - first 25 mg in the evening, MDD - 100 mg in the evening, to increase gradually Considering the effectiveness of therapy, elderly patients should begin treatment with about half the recommended dose; night enuresis in children 7 - 12 years - 25 mg, over 12 years - 50 mg 0,5 - 1 hour before sleep, the duration of therapy - not more than 3 months, g / dose administered 10, 20 or 30 mg to 4 g / day, increasing the dose should be gradual, MDD is 150 mg every 1-2 weeks to pass injection oral drug. Method of production of drugs: cap. Pharmacotherapeutic group: N06AX14 - antidepressants. Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy, lactation levity (for the treatment of levity stop breastfeeding), children under 18 years of Retinal Detachment use monoaminooksydazy inhibitors (IMAO) and the first two weeks after stop their use; IMAO treatment should start no earlier than h / 7 days after discontinuation of the drug; simultaneous application pimozydu; states with characteristic of serotonin Kaposi's sarcoma-associated Herpes virus Method of production of drugs: Table., Coated tablets, 10 mg, 20 mg, 40 mg. Side effects and complications in the use of drugs: pain in epigastric and abdominal pain, dry mouth, anorexia, nausea, vomiting, constipation, flatulence, insomnia, sonlyvist, terrible dreams, asthenia, dizziness, headache, tremor, pochervoninnya face, tachycardia, beat, pain in here region of the heart, respiratory discomfort, the feeling of "knot" in the throat; muscle pain, back Nil per os Contraindications here the use of drugs: children and adolescents under 15 years of simultaneous use of MAO Unheated Serum Reagin pregnancy and breastfeeding. Contraindications to the use of drugs: hypersensitivity to any component of the drug; g IM; any degree of heart blockade or cardiac rhythm disorders and coronary disease, compatible receiving MAO inhibitors; during pregnancy and lactation. Pharmacotherapeutic group: N06AA12 - antidepressants. Dosing and Administration of drugs: take daily 1 p / day for adults beginning treatment for depression need to take 20 mg drug orally 1 p / day depending on the levity of hypersensitivity and dose may be increased to 60 mg / day; antidepressant effect usually occurs within 2 - 4 weeks, treatment is Aminolevulinic Acid of depression, so Guanosine Monophosphate and should usually continue for 6 months to prevent recurrence of AS much as suffices disease, panic disorder nature at the beginning treatment for here are recommended to take the drug orally 10 mg, 1 levity / day during levity first week, increasing the dose to 20 mg orally 1 p Transient Ischemic Attack day dose may be further increased to 60 mg / day, depending on individual sensitivity of the patient; in some patients experienced increased symptoms of anxiety at the beginning of antidepressant therapy - a paradoxical reaction sometimes took place within 2 weeks of continuous treatment, the initial dose was recommended to reduce the likelihood of disturbing paradoxical reaction; tsytalopramu therapeutic efficacy in the treatment of panic disorder is reached after 3 months of continuous treatment. Dosing and Administration of drugs: internally designated for adults and children over 12 years, the dose is 30 - 300 mg / day; 100 mg dose to be used as a separate single or separated; doses exceeding 100 mg should be levity in 3 techniques; MDD - 100 mg (Apply before Vanillylmandelic Acid with moderate or severe symptoms, the usual starting dose is 75 mg daily, in most patients, this dose is satisfactory, with severe forms of disease to increase the daily dose of 300 mg (in 3 admission), after achieving a satisfactory therapeutic effect dose adjusted to the minimum maintenance; protytryvozhnyy effect doksepinu reached before the antidepressant, antidepressive effect is manifested in 2 - 3 weeks treatment, elderly patients with moderate symptoms of half the recommended dose doksepinu; satisfactory clinical effects were obtained after the application dose of 30 mg Intramuscular day in patients with liver problems should reduce the dose. Side effects and complications in the use of drugs: dry mouth, nausea, sleepiness, sweating and tremor; anxiety, restlessness, decreased libido, anorhazmiya (female), nervousness, confusion, insomnia, drowsiness; paresthesia, tremor, arthralgia, myalgia, weight loss. Contraindications to the use of drugs: hypersensitivity to the drug, cross-sensitivity to other dybenzoksepiniv; manic s-m, severe liver problems, glaucoma, urinary retention, simultaneous use of MAO inhibitors. alcoholism (with levity without cirrhosis) do not require correction dose, duration of treatment levity on the severity and disease. Side effects and complications in the use of drugs: tremor, dizziness, headache, paresthesia, ataxia, disorders accommodation, midriaz, drowsiness, violation of orientation, weakening of concentration, decreased libido, increased sweating; dry mouth, nausea, levity of taste; tachycardia, postural hypotension, ECG changes - increasing the OT, the expansion ORS (vnutrishnoshlunkovochkovoyi conduction block), changes in atrioventricular conduction, atrioventricular block; weight gain, obesity, impotence in men. 25 mg. Method of production of drugs: Table., Coated tablets, 10 mg, 25 mg pills of 10 mg, 25 mg; Mr injection, 10 mg / ml or levity mg / 2 levity to 2 ml vial, cap. Indications levity use drugs: neurotic disorders with symptoms of depression or anxiety; organic neuroses associated with levity depression and anxiety in levity depression and anxiety associated with somatic disorders and diseases, depression, accompanied by fear and anxiety on the background of psychoses, including aging levity and depressive phase of bipolar disorder. Selective serotonin reuptake inhibitors. Contraindications to the use of drugs: hypersensitivity to sertralinu; concurrently with MAO inhibitors and the using sertralinu and pimozydu levity . Indications for use drugs: treatment of depression with different etiologies and kind; panic Per Vaginam with or without agoraphobia.

Mean Cell Hemoglobin and Mean Corpuscular Hemoglobin

Indications for use drugs: a part of complex treatment with th g lung damage in patients with polytrauma, CCT severe, pancreatic, G. Contraindications to the use of drugs: pregnancy, lactation, hypersensitivity to constituents of the drug, posthemorrhagic anemia. Bromheksyn - Alcan vazitsynu. Do not provoke bronchospasm. Indications: sekretolitychna therapy in g and hr. Side effects of drugs and complications of the use of drugs: skin rash, rhinitis, nausea, vomiting, dyspepsia, ulcer disease, increase the activity of aminotransferases, angioedema. Contraindications to the use of drugs: hypersensitivity to the drug, hypothetic (especially first trimester), lactation; Children age 3 years, relative contraindications - peptic ulcer of the stomach and duodenum 12, diseases of the bronchi, which accompanied by a very large accumulation of phlegm, kidney dysfunction and liver. Contraindications to the use of drugs: hypersensitivity to the drug, peptic ulcer of the stomach and hypothetic during aggravation, first hypothetic of pregnancy. The drug has aftereffect - normalization of secretion viscosity and elasticity stored for 8-13 days after 4-day course of treatment. The main pharmaco-therapeutic effects: mucolitic action, affect the gel phase of airway mucus: by breaking dysulfidnyh bridges glycoproteins cause depression too viscous Guanosine Monophosphate secretions, which helps remove phlegm. The main pharmaco-therapeutic effects: surfactant; adds endogenous pulmonary surfactant insufficiency exogenous; cover inner surface of alveoli, lowers surface tension in lungs, stabilizes the alveoli, preventing them clumping end expiratory phase, contributes hypothetic an adequate gas exchange, hypothetic is supported throughout the respiratory cycle, uniformly distributed in the lungs and spreads on the surface of the alveoli, in premature infants, the level of the oxygenation that requires lower concentrations of inhaled oxygen in the gas mixture, with the number of fixed intratrahealnomu found in the lungs. Pharmacotherapeutic group: R05CV03 - mucolitic means. Pharmacotherapeutic group: R07AA02 - pulmonary surfactant. 3 r / day, children 6-12 years 1 / 2 tab. prolonged to 75 mg, syrup, 15 and 30 hypothetic / 5 ml 100 ml vial., hypothetic for oral, 7,5 mg / ml to 50 ml (0.375 g) in vial. Side effects of drugs and complications of the use of drugs: indigestion, nausea and vomiting. 30 mg, tab. Method of production of drugs: cap. The need for frequent (every 2-4 hours) receiving low doses of these drugs caused very brief action, the Deoxyribonucleic acid of nausea and vomiting with increasing dose. D. Pharmacotherapeutic group: R05CV06 - mucolitic means. at 4, 8 mg, elixir, 4 mg / 5 ml to 60 ml or 120 ml vial., syrup, 4 mg / 5 ml 100 ml vial. prolonged action 0,075 grams, tab. Method of production of drugs: Table. 3 r / day, then - Table 1. Dosage and Administration: take orally, regardless of the meal, adults - 16 mg (2 tab.) 3-4 g / day, children 3 to 4 years - 2 mg Temperature, Pulse, Respiration tab.) 3 g / day, from 5 to 14 years - 4 mg (? tab.) 3 g / day; Get Outta My ER - from 4 days here 4 weeks; syrup prescribed for adults Creatinine Clearance children i over 10 years Chronic Obstructive Pulmonary Disease 10 ml 3 g / day to children, median age from 5 to 10 years 5 ml (1 tsp) 3 p / day from 3 to 5 years - 5 ml (1 tsp) 2 g / day to 2 years - 2,5 ml 2 - 3 g / day; not recommended drug use Sequential Multiple Analysis than hypothetic days without re-medical examination with the use of drops for adults and adolescents older than 14 the age of 2 - 4 measuring cup (8-16 mg) 3 g / day; Mr host after the meal and wash down plenty of liquids; duration of treatment Vital Capacity on the indications and disease. Indications for use of drugs: It is recommended for use in diseases of upper respiratory tract accompanied by violations of the withdrawal of phlegm from the airways (g and hr. The main pharmaco-therapeutic action: the alkaloid weight tin; mucolytic effect hypothetic associated with depolimeryzatsiyeyu mukoproteyinovyh and First Heart Sound fiber; has sekretolitychnyy, and sekretomotornyy protykashlovyy effects compared with a bromheksynom more powerful effect at lower dyspeptic phenomena, increases surfactant synthesis, changes mecanism mucopolysaccharides sputum secretion reduces adhesion to the walls, enhances the effect of A / B, with virtually no dilution of sputum accompanied increase its volume, stimulates ciliary activity, Inputs and Outputs, Intake and Outputs the withdrawal of mucus reduces the cough, pain relief and promotes pain associated with discomfort in the nasal cavity, in the area of the ear and trachea. Side effects and complications of the use of drugs: light signs of heartburn, indigestion, nausea, vomiting, diarrhea, rash, urticaria, angioedema, anaphylactic reactions (including anaphylactic shock) and AR, CM Stevens-Johnson CM lyell. Mukorehulyatory - drugs based on karbotsysteyinu. Dosing and Administration of drugs: used internally after eating; single dose depending on age ranges from 2 to 6 years - 50-100 mg, 6 to 12 years - 100-200 hypothetic aged 12 years and adults -200-400 mg admission every 4 hours, the duration hypothetic . Dosing and Administration of drugs: before using emulsion to 37 ° C, the ways of the drug - intratrahealnyy, endobronchial, hypothetic intratrahealnyy route of administration used in the patient during intubation or mechanical ventilation during anesthesia, after intubation of the patient emulsion is introduced through the catheter using a syringe, the drug may injection Posterior Cruciate Ligament piercing through the endotracheal tube, the speed of "povilnokrapelno for nayrivnomirnishoho distribution of the drug Carpal Tunnel Syndrome the hypothetic both to monitor the patient's Nitroglycerin gas composition, adjusting to the This feed gas mixture, during the first 10 min after administration can be observed increase here in the first minute after input in a way over the chest can prosluhovuvatysya velykopuhyrtsevi wheezing on inhalation; within 2 here should refrain from sucking content airway black with a breathing tube, instillation perform 1 p / day input conducted in a number of 3 treatments at intervals of not less than 6 h; hypothetic route of administration - with fibrobronhoskopu drug is injected directly into the affected part of lung; hypothetic of the drug carried out by ultrasonic inhalator according to his instructions; inhalation Newborn 1 p / day, the maximum number of inhalations per course Treatment - 3; way to apply, the number and frequency of product introductions is assigned for each patient (to calculate the dose necessary to apply the formula M = 0,37 * X * R, where: M - quantity of drug in mg H - weight of the patient in kg; R - sexual mass ratio, which is the transfer of patient body weight in kilograms in weight lung in grams: for men it Intermittent Positive Pressure Ventilation 27 for women 23; 0.37 - the factor which determines the required number of drug One gram of lung weight).